Your browser doesn't support javascript.
loading
53BP1 regulates heterochromatin through liquid phase separation.
Zhang, Lei; Geng, Xinran; Wang, Fangfang; Tang, Jinshan; Ichida, Yu; Sharma, Arishya; Jin, Sora; Chen, Mingyue; Tang, Mingliang; Pozo, Franklin Mayca; Wang, Wenxiu; Wang, Janet; Wozniak, Michal; Guo, Xiaoxia; Miyagi, Masaru; Jin, Fulai; Xu, Yongjie; Yao, Xinsheng; Zhang, Youwei.
Afiliación
  • Zhang L; Department of Pharmacology, Case Comprehensive Cancer Center, Case Western Reserve University, School of Medicine, Cleveland, OH, 44106, USA. zhanglei0222@163.com.
  • Geng X; National 111 Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering, Hubei University of Technology, Wuhan, Hubei, 430068, China. zhanglei0222@163.com.
  • Wang F; Department of Pharmacology, Case Comprehensive Cancer Center, Case Western Reserve University, School of Medicine, Cleveland, OH, 44106, USA.
  • Tang J; Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy, Jinan University, Guangzhou, 510632, China.
  • Ichida Y; Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy, Jinan University, Guangzhou, 510632, China.
  • Sharma A; Department of Pharmacology, Case Comprehensive Cancer Center, Case Western Reserve University, School of Medicine, Cleveland, OH, 44106, USA.
  • Jin S; Department of Pharmacology, Case Comprehensive Cancer Center, Case Western Reserve University, School of Medicine, Cleveland, OH, 44106, USA.
  • Chen M; Department of Pharmacology, Case Comprehensive Cancer Center, Case Western Reserve University, School of Medicine, Cleveland, OH, 44106, USA.
  • Tang M; National 111 Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering, Hubei University of Technology, Wuhan, Hubei, 430068, China.
  • Pozo FM; College of Life Sciences, Wuhan University, Wuhan, Hubei, 430068, China.
  • Wang W; Department of Pharmacology, Case Comprehensive Cancer Center, Case Western Reserve University, School of Medicine, Cleveland, OH, 44106, USA.
  • Wang J; National 111 Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering, Hubei University of Technology, Wuhan, Hubei, 430068, China.
  • Wozniak M; Department of Genetics and Genome Sciences, Case Western Reserve University, School of Medicine, Cleveland, OH, 44106, USA.
  • Guo X; Department of Pharmacology and Toxicology, Wright State University, Dayton, OH, 45435, USA.
  • Miyagi M; Department of Molecular Biology of Cancer, Medical University of Lodz, 6/8 Mazowiecka Street, 92-215, Lodz, Poland.
  • Jin F; National 111 Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering, Hubei University of Technology, Wuhan, Hubei, 430068, China.
  • Xu Y; Department of Pharmacology, Case Comprehensive Cancer Center, Case Western Reserve University, School of Medicine, Cleveland, OH, 44106, USA.
  • Yao X; Department of Genetics and Genome Sciences, Case Western Reserve University, School of Medicine, Cleveland, OH, 44106, USA.
  • Zhang Y; Department of Pharmacology and Toxicology, Wright State University, Dayton, OH, 45435, USA.
Nat Commun ; 13(1): 360, 2022 01 18.
Article en En | MEDLINE | ID: mdl-35042897

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Heterocromatina / Proteína 1 de Unión al Supresor Tumoral P53 Límite: Animals Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Heterocromatina / Proteína 1 de Unión al Supresor Tumoral P53 Límite: Animals Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos